◼ Archived
Business
🔮 Newsylist predicts: still trending tomorrow low confidence — graded ✗ wrong
Eli Lilly inks $2.88B Merida buyout for autoimmune drugs against rogue antibodies
7sources
8articles
5velocity
+0%since first seen
20d agofirst detected
Text:
🤖 AI Dossier
Sources (8)
-
-
-
-
-
-
-
-
Eli Lilly inks $2.88B Merida buyout for autoimmune drugs against rogue antibodies Fierce Biotech · 20d ago broke it first
How fast it spread
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
📊 AUDIENCE & LONGEVITY PULSE
How do you expect this trend to evolve over the next 24 hours?
Cast your vote to register reader intelligence on the velocity and trajectory of this coverage.
Related trends
↑ Rising
Business
🔮 holds
Polymarket’s Rush to Grow Left a Door Wide Open For Fraudsters
↑ Rising
Business
🔮 holds
Big Tech uses guarantees to keep $300bn of AI exposure off balance sheets
▲ Peaking
Business
🔮 holds
North Korean WaterPlum hackers infected 30,000 devices worldwide
↓ Cooling
Business
🔮 fades
What It’s Like to Work in One of America’s Data Centers
▲ Peaking
Business
🔮 holds
China keeps benchmark lending rates unchanged for 16th month in September
▲ Peaking
Business
🔮 holds